GlassScriptPhysician profile
Priyanka Sen
NPI 1427318260
$12,581.55
in general payments reported to CMS, 2019-2025
46 companies · $1,823 in 2025
The $1,823 reported for 2025 was more than what 82% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $2,248 · 2021: $2,819 · 2022: $2,165 · 2023: $1,983 · 2024: $1,544 · 2025: $1,823.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,349.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,671.38 | 2020 | |
| Abbott Laboratories | $1,421.48 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Perclose Prostyle |
| E.R. Squibb & Sons, L.L.C. | $956.59 | 2020-2025 | Eliquis, Camzyos |
| Abiomed | $829.14 | 2022-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $786.14 | 2021-2025 | Lifevest |
| Impulse Dynamics (USA) INC. | $719.62 | 2021-2023 | Optimizer |
| Medtronic, INC. | $599.66 | 2021-2025 | Corevalve Evolut R, Na |
| Janssen Pharmaceuticals, INC | $554.88 | 2021-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $497.30 | 2021-2025 | |
| Boston Scientific Corporation | $468.19 | 2022-2025 | General - Therapies, Eluvia, Bodyguardian |
| Novo Nordisk INC | $423.86 | 2022-2025 | Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $417.19 | 2020-2025 | Farxiga |
| Actelion Pharmaceuticals US, INC. | $359.96 | 2021-2024 | Uptravi, Opsumit |
| Pfizer INC. | $326.68 | 2020-2025 | |
| Edwards Lifesciences Corporation | $317.23 | 2020-2022 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $304.63 | 2020-2025 | Jardiance |
| Amgen INC. | $278.32 | 2021-2025 | Repatha, Repatha |
| Inari Medical, INC. | $223.30 | 2021-2022 | |
| Atricure, INC. | $158.64 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $125.01 | 2023 | |
| Esperion Therapeutics, INC. | $91.36 | 2020-2024 | Nexletol |
| Cvrx, INC. | $85.45 | 2021-2025 | Barostim Neo System |
| Angiodynamics, INC. | $81.07 | 2021-2022 | |
| Endologix LLC | $73.00 | 2021-2022 | |
| Chiesi USA, INC. | $69.18 | 2021-2022 | |
| Daiichi Sankyo INC. | $65.97 | 2023 | Injectafer |
| Heartflow, INC. | $63.52 | 2024 | |
| Lexicon Pharmaceuticals, INC. | $60.33 | 2023 | Inpefa |
| Baxter Healthcare | $59.35 | 2024-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Shockwave Medical, INC | $55.56 | 2021-2022 | |
| Irhythm Technologies, INC. | $47.06 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Amarin Pharma, INC. | $45.30 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $44.96 | 2023 | Arcalyst |
| Inspire Medical Systems, INC. | $44.11 | 2024 | Inspire |
| Cleerly, INC. | $37.17 | 2024 | Cleerly Ischemia, Cleerly Labs |
| Cardiovascular Systems INC. | $32.86 | 2020 | |
| Alnylam Pharmaceuticals INC. | $28.30 | 2021 | |
| Surmodics, INC. | $26.61 | 2022 | |
| Portola Pharmaceuticals, LLC | $21.42 | 2020 | |
| Medicomp INC | $20.52 | 2023 | Telepatch Cardiac Monitor |
| Merck Sharp & Dohme LLC | $16.43 | 2022 | |
| Arbor Pharmaceuticals, INC. | $15.36 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $15.21 | 2024 | Arcalyst |
| Cashflow Solutions, LLC | $14.45 | 2024 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Cardiva Medical, INC. | $14.02 | 2022 | |
| Kestra Medical Technology Services, INC. | $13.78 | 2025 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priyanka Sen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.